Data Integrity for Effective Data Governance in Biopharma

Data Integrity

Implementing Data Integrity for Effective Data Governance in Biopharma

Description

Data Integrity is a fundamental principle of Good Manufacturing Practices (GMP). Over the past four years, both the FDA and European inspectors have reported numerous citations related to data integrity.  Many US Warning Letters and EU Non-Compliance Reports deal with serious Data Integrity violations. Data Integrity questions have been and will continue to be the focus of many GMP inspections.

Why should you attend

As a consequence, international authorities – FDA, EMA, PIC/S, WHO, MHRA – published guidance documents to describe the regulatory expectations of Data Integrity. Although not all guidelines are intended to impose an additional regulatory burden on the regulated companies, a lot of uncertainty predominates the pharmaceutical industry on how to implement these requirements into the daily business.

Objectives

  • Get familiar with the current regulatory requirements on data integrity and how regulators refine these requirements
  • Get a deeper understanding of what FDA and European inspectors expect from pharmaceutical companies regarding Data Integrity
  • Learn how to implement the (new) regulatory requirements on Data Integrity into your Pharmaceutical Quality System
  • Learn how to prepare your company for a successful inspection regarding Data Integrity
  • Understand how to establish an effective Data Governance System
  • Learn how to investigate Data Integrity issues in your company

Who Should Attend

  • Managers and staff from Manufacturing, QC/QA, and Analytical Development Laboratories of pharmaceutical companies
  •  Contract Research Organisation and Contract Manufacturing Organisation manufacturing, laboratory, and QA personnel
  •  Auditors (internal and external) are responsible for performing self-inspections or external audits and need to understand and assess data integrity

Education Approach

  • This training is based on both theory and best practices used in the implementation and management of GDP
  • Lecture sessions are illustrated with examples based on case studies
  • Practical exercises are based on a case study, which includes role-playing and discussions

Speaker

Kossi Molley, Chgemiste; LSSBB: PMP

  • Date : 2026-03-10
  • Venue : Online

Tickets

From $399.99

Related Events

New_GUI-0158-NHP-01
English Masterclass
Online

A Deep Dive into Health Canada’s NHP GMP, GUI-0158, Version 4: Your Blueprint for Compliance

This intensive one-day workshop provides an in-depth review

Advanced_Stability
English Masterclass
Validation des procédés: Qualification de la performance des procédés
French Webinar
Online

Validation des procédés: Qualification de la performance des procédés

Ce programme de formation complet aborde les aspects

MGP-PPQ-EN
English Masterclass
Online

Process Validation: Performance Qualification

This comprehensive training program will cover the critical